One hundred four (104) additional individuals have been confirmed positive for COVID-19 in the CNMI, bringing the CNMI total to 1,062 cases since March 28, 2020.
There are currently 8 individuals hospitalized as a result of COVID-19 (7 unvaccinated, 1 vaccinated; 0 on a ventilator).
Unvaccinated individuals are at risk of serious illness from COVID-19, and unvaccinated individuals spread the virus at a higher rate than vaccinated individuals, thereby increasing the spread and risk of serious illness toward other unvaccinated individuals.
Vaccines are the best protection against the highly transmissible virus, and are readily available at the Multi-Purpose Center, Monday to Saturday, 8 a.m. – 4 p.m. Register for COVID-19 vaccines at www.vaccinatecnmi.com, or walk into the Multi-Purpose Center to request a booster shot. Individuals age 18 or older are now eligible to avail of a booster shot at the Multi-Purpose Center.
The CHCC highly encourages unvaccinated individuals to get vaccinated or get a booster shot against COVID-19 to help prevent severe illness, hospitalization, and death. Data from small clinical trials show that vaccine effectiveness against COVID-19 infection is waning after the primary series, but protection remains high against severe disease and hospitalization.
The newly identified individuals were confirmed through surveillance testing from Nov. 30 to Dec. 1, 2021. The individuals have been isolated and are actively monitored.
Of the 104 new cases, 23 were identified via community testing and 81 via contact tracing. Of the 81 identified via contact tracing, 52 were identified while in quarantine. The vaccination statuses of the 104 new cases are pending verification.
A total of 303 COVID-19 vaccine shots were administered on Dec. 1, 2021, resulting in 87.3% of the CNMI’s eligible population being fully vaccinated, which affords the community more protection against severe illness, hospitalization, and death.
Since Oct. 28, 2021, there have been 771 new cases, of which 400 were identified via contact tracing, 359 were identified via community testing, and 12 were identified via travel testing.
A total of 811 COVID-19 tests were conducted on Dec. 1, 2021, which comprises travel testing and surveillance testing.
The CHCC Communicable Disease Investigation/Inspection team has already initiated contact tracing for the most immediate contacts of the newly confirmed cases, and this effort will continue until all probable cases are identified and tested. Our contact tracers will reach out to individuals who are deemed high risk. The associated risk of infection depends on the level of exposure, which will, in turn, determine the type of monitoring. Establishing the level of exposure can be difficult and requires investigation.